All companies
Visit website
MAKANI SCIENCE
OperatingMakani Science Inc.
Healthcare · Founded 2018
Better breathing, better health
Post-money valuation ⓘ
$11.8M
As of Mar 2023 · from Makani Science Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$39,396
Across 1 round since 2022
Latest share price
$0.67
Makani Science Common Stock 1 offering price
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its source$0
−$308K
2020
$0
−$700K
2021
$0
−$659K
2022
$0
−$250K
2023
$0
−$259K
2024
$111K
−$409K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
$0
$111,059
Cost of goods sold
$0
$0
$0
$0
$0
$0
Gross margin
—
—
—
—
—
100%
Net income
-$307,578
-$700,431
-$658,949
-$250,224
-$258,997
-$408,859
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$645,937
$667,116
$79,168
$48,693
$37,664
$312,123
Accounts receivable
$0
$0
$0
$0
$0
$0
Total assets
$645,937
$667,116
$79,168
$48,693
$37,664
$312,123
Short-term debt
$3,231
$4,788
$60,588
$85,683
$103,712
$84,464
Long-term debt
$369,947
$480,000
$480,000
$605,000
$0
$1,439,800
Total liabilities
$373,178
$484,788
$540,588
$690,683
$103,712
$1,524,264
Other
Headcount
—
3
—
3
—
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$11.8M
post-money
Makani Science Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $39.4K / $1.2MInvestors 88Post-money $11.8M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 4 annual reports (FY2022–FY2025)
88 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001960426Share price $0.67
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.